Expediting approval for medical countermeasures to address high burden disease: an ethical justification to move beyond emergency use authorisation

Global burden and trends of neglected tropical diseases from 1990 to 2019

(2022) Yushi Lin et al.   JOURNAL OF TRAVEL MEDICINE

Crowdfunding narratives and the valuation of vaccines for COVID-19

(2022) Jeremy Snyder et al.   VACCINE

Efficacy and immunogenicity of R21/Matrix-M vaccine against clinical malaria after 2 years' follow-up in children in Burkina Faso: a phase 1/2b randomised controlled trial

(2022) Mehreen S Datoo et al.   LANCET INFECTIOUS DISEASES

Should health research funding be proportional to the burden of disease?

(2022) Joseph Millum   Politics Philosophy & Economics

Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial

(2021) Mehreen S Datoo et al.   LANCET

SARS-CoV-2 Human Challenge Studies — Establishing the Model during an Evolving Pandemic

(2021) Garth Rapeport et al.   NEW ENGLAND JOURNAL OF MEDICINE

Avoiding Exceptionalism and Silver Bullets: Lessons from Public Health Ethics and Alzheimer’s Disease

(2021) Ignacio Mastroleo et al.   AMERICAN JOURNAL OF BIOETHICS

Helpful Lessons and Cautionary Tales: How Should COVID-19 Drug Development and Access Inform Approaches to Non-Pandemic Diseases?

(2021) Holly Fernandez Lynch et al.   AMERICAN JOURNAL OF BIOETHICS

When does a major outbreak become a Public Health Emergency of International Concern?

(2020) David N Durrheim et al.   LANCET INFECTIOUS DISEASES

Facilitating Both Evidence and Access: Improving FDA's Accelerated Approval and Expanded Access Pathways

(2020) Holly Fernandez Lynch et al.   JOURNAL OF LAW MEDICINE & ETHICS

Public health emergencies of international concern: a historic overview

(2020) Annelies Wilder-Smith et al.   JOURNAL OF TRAVEL MEDICINE

The granting of emergency use designation to COVID-19 candidate vaccines: implications for COVID-19 vaccine trials

(2020) Jerome Amir Singh et al.   LANCET INFECTIOUS DISEASES

RTS,S/AS01 Vaccine (Mosquirix™) : An overview

(2019) Matthew B. Laurens   Human Vaccines & Immunotherapeutics

The Health Gap: The Challenge of an Unequal World: the argument

(2017) Michael Marmot   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study

(2012) Fatimah S Dawood et al.   LANCET INFECTIOUS DISEASES

The Age-Specific Cumulative Incidence of Infection with Pandemic Influenza H1N1 2009 Was Similar in Various Countries Prior to Vaccination

(2011) Heath Kelly et al.   PLoS One